120 related articles for article (PubMed ID: 6239836)
1. Chlorozotocin: results in colorectal carcinoma treated with high and low doses. A Southwest Oncology Group study.
Haas CD; McCracken JD; Vaughn CB; Stephens RL; Bukowski RM; Eyre HJ
Invest New Drugs; 1984; 2(4):401-4. PubMed ID: 6239836
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial with chlorozotocin in advanced colorectal cancer.
Bleiberg H; Rozencweig M; Michel J; Clavel M; Longeval E; Feremans W; Bondue H; Lardinois J; Crespeigne N; Kenis Y
Eur J Cancer Clin Oncol; 1981 Aug; 17(8):863-6. PubMed ID: 6459936
[No Abstract] [Full Text] [Related]
4. A phase II study of chlorozotocin in advanced large bowel carcinoma. A cooperative study between two institutions.
Schutt AJ; Hoth D; Moertel CG; Schein PS; Rubin J; O'Connell MJ
Am J Clin Oncol; 1984 Oct; 7(5):507-11. PubMed ID: 6239538
[TBL] [Abstract][Full Text] [Related]
5. ECOG phase II trials of MGBG, chlorozotocin, COM multidrug therapy in advanced measurable colorectal cancer.
Douglass HO; Lefkopoulou M; Davis HL; Taylor SG; Falkson G; Mittelman A; MacIntyre J; Engstrom PF
Am J Clin Oncol; 1988 Dec; 11(6):646-9. PubMed ID: 2973226
[TBL] [Abstract][Full Text] [Related]
6. Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group.
Cancer Treat Rep; 1985 Apr; 69(4):417-20. PubMed ID: 2859924
[TBL] [Abstract][Full Text] [Related]
7. Phase I evaluation of chlorozotocin: single dose every six weeks.
Taylor S; Belt RJ; Haas CD; Stephens RL; Hoogstraten B
Cancer; 1980 Dec; 46(11):2365-8. PubMed ID: 6449279
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of chlorozotocin in metastatic malignant melanoma.
Hoth DF; Schein PS; Winokur S; Woolley PV; Robichaud K; Binder RB; Smith FP
Cancer; 1980 Oct; 46(7):1544-7. PubMed ID: 6448088
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of 10-deaza-aminopterin in patients with advanced colorectal cancer.
Cheng EW; Currie VE; Yagoda A
Am J Clin Oncol; 1983 Aug; 6(4):469-71. PubMed ID: 6869317
[TBL] [Abstract][Full Text] [Related]
11. CBDCA: phase II evaluation in advanced colorectal carcinoma.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Apr; 10(2):136-8. PubMed ID: 3551576
[TBL] [Abstract][Full Text] [Related]
12. Phase I evaluation of chlorozotocin (NSC-178248): weekly schedule.
Moriconi WJ; Taylor S; Slavik M; Belt RJ; Haas CD; Hoogstraten B
Invest New Drugs; 1985; 3(1):57-62. PubMed ID: 3157661
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of chlorozotocin: attempted amelioration of myelotoxicity by glucose administration.
Panasci L; Comis R; Ginsberg S; Kohn L; Fitzpatrick A; Rubert M; Scalzo T
Cancer Treat Rep; 1981; 65(7-8):647-50. PubMed ID: 6454483
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of chlorozotocin in islet cell carcinoma. A southwest Oncology Group study.
Bukowski RM; McCracken JD; Balcerzak SP; Fabian CJ
Cancer Chemother Pharmacol; 1983; 11(1):48-50. PubMed ID: 6309425
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).
Creech RH; Stanley K; Vogl SE; Ettinger DS; Bonomi PD; Salazar O
Cancer Treat Rep; 1982 Jun; 66(6):1417-9. PubMed ID: 6282460
[TBL] [Abstract][Full Text] [Related]
16. Chlorozotocin treatment of advanced gastrointestinal cancer.
Veronesi A; Magri MD; Tirelli U; Galligioni E; Figoli F; Zagonel V; Tumolo S; Grigoletto E
Med Pediatr Oncol; 1983; 11(5):365-6. PubMed ID: 6226856
[TBL] [Abstract][Full Text] [Related]
17. PCNU: phase II evaluation in advanced colorectal carcinoma.
Pazdur R; Samson MK; Baker LH
Invest New Drugs; 1988 Jun; 6(2):93-5. PubMed ID: 3170134
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of chlorozotocin.
Gralla RJ; Tan CT; Young CW
Cancer Treat Rep; 1979 Jan; 63(1):17-20. PubMed ID: 154363
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
Earhart RH; Moertel C; Hahn RG; Woodhouse CL; Ramirez G; Engstrom PF
Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
[TBL] [Abstract][Full Text] [Related]
20. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
